Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Marriott Officer Breland Files to Sell 2,500 Class A Shares

Marriott International Inc /MD/ officer Benjamin T. Breland filed a Form 144 notice of proposed sale on November 4, 2026, covering 2,500 Class A shares with an aggregate market value of $1,058,300.00.

Shwetambri Chauhan | 04 November 2026

OPENLANE Q3 2026: Revenue Rises to $561.2M, Preferred Stock Converted

OPENLANE, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 4, 2026, reporting third-quarter total operating revenues of $561.2 million and the full conversion of its Series A convertible preferred stock.

Aditi Sarkar | 04 November 2026

Debbi Nir Sells 14,582 Global-E Shares on Nov 2, 2026

Global-E Online Ltd. President and Director Debbi Nir filed a Form 4 on November 4, 2026, disclosing the sale of 14,582 ordinary shares on November 2, 2026, pursuant to a Rule 10b5-1 trading plan.

Aditi Sarkar | 04 November 2026

Alex Gusinov Exercises 3,075 Vicor Options on Nov. 3

Alex Gusinov, Corporate VP of Engineering at Vicor Corp, filed a Form 4 on November 4, 2026, disclosing the exercise of three tranches of non-qualified stock options on November 3, 2026, covering a combined 3,075 shares of common stock.

Shwetambri Chauhan | 04 November 2026

UBS Group AG Reports Zero Units Held in Starlink AI

UBS Group AG filed an amended Schedule 13G with the SEC on November 4, 2026, disclosing a beneficial ownership position of 0.00 units in Starlink AI Acquisition Corp as of September 30, 2026.

Nitish Kishor | 04 November 2026

City Holding Q3 2026: Net Interest Income Rises to $62.6M

City Holding Company filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 4, 2026, reporting third-quarter net interest income of $62,605 thousand and total assets of $6,786,251 thousand.

Aakashdeep | 04 November 2026

Seres Therapeutics Q3 2026: Going Concern Doubt Disclosed

Seres Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 4, 2026, disclosing going concern doubt and an ongoing need for additional funding.

Anjali Anand | 04 November 2026

Atlas Critical Minerals CFO Lira Files Initial Ownership Form

Santiago Virgilio Lira, CFO and Treasurer of Atlas Critical Minerals Corp, filed a Form 3 initial statement of beneficial ownership with the SEC on November 4, 2026, disclosing no securities beneficially owned as of the event date of April 7, 2026.

Nitish Kishor | 04 November 2026

Embotelladora Andina Posts Nine-Month 2026 Net Income of ThCh$198.4B

Embotelladora Andina S.A. filed a Form 6-K with the SEC on November 4, 2026, furnishing consolidated interim financial statements for the nine months ended September 30, 2026 (non-audited) and the year ended December 31, 2025.

Manish Choudhary | 04 November 2026

RBC Enhanced Return Notes Linked to Five-Index Basket, Due 2031

Royal Bank of Canada filed a free writing prospectus on November 4, 2026, disclosing terms for Enhanced Return Notes linked to a basket of five international equity indices, with a maturity date of November 28, 2031.

Aditi Sarkar | 04 November 2026
Support

Hi! How can we help you today?

Loading…